This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk Healthcare Ag. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Claus Kristensen: Innovator in Coagulation Factor IX
Introduction
Claus Kristensen is a notable inventor based in Nivaa, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins. His work focuses on improving treatments for conditions related to blood coagulation.
Latest Patents
Claus Kristensen holds a patent for "Hyperglycosylated human coagulation factor IX." This invention pertains to hyperglycosylated human coagulation factor IX polypeptides, processes for preparing these polypeptides, pharmaceutical compositions that include them, and their use in treating diseases alleviated by human coagulation factor IX, especially hemophilia. He has 1 patent to his name.
Career Highlights
Claus Kristensen is associated with Novo Nordisk Healthcare AG, a leading global healthcare company specializing in diabetes care and other chronic conditions. His role at the company has allowed him to contribute to innovative solutions in the medical field.
Collaborations
One of his notable coworkers is Gert Bolt, with whom he has likely collaborated on various projects within the company.
Conclusion
Claus Kristensen's work in the development of hyperglycosylated human coagulation factor IX represents a significant advancement in the treatment of hemophilia and related disorders. His contributions continue to impact the field of biotechnology positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile